Evolva expands collaboration with IFF

07-05-2012: Evolva Holding SA announced that it has expanded its collaboration with International Flavors & Fragrances Inc. Evolva has been working with IFF since early 2011 to implement a commercially viable biosynthetic route for the sustainable production of a key flavouring ingredient. This project is progressing on schedule. The collaboration is now expanded to include an additional flavouring ingredient.

Under the four year agreement, IFF will fund research and development activities at Evolva, focused primarily on pathway discovery and yield stages of the programme through the scale-up and manufacturing phases. Evolva will receive an upfront payment as well as monthly research fees. Furthermore, Evolva will receive royalty on product sales based on both margin and volume.

Neil Goldsmith, CEO of Evolva, said “Our first project with IFF is progressing well and we are excited about extending the collaboration. It is clear our biosynthesis platform is delivering radically new products and processes. These have the potential to open up markets that were previously constrained by cost, production or supply chain factors.”

Contact / Request information

Request further information free of charge:

Request information now

Watchlist

This is where you can add this news to your personal favourites

On my watchlist

Request information now On my watchlist

Facts, background information, dossiers

Evolva
flavours
IFF

More about Evolva

News

Evolva reaches milestone in BASF collaboration

Evolva Holding SA announced that it has achieved a key milestone in its collaboration with BASF. The collaboration involves joint research on the design of novel and optimised biosynthetic routes for a natural product with crop protection potential. Evolva has produced a yeast strain that a ... more

Evolva in collaboration with Ajinomoto Co

Evolva Holding SA announced that it has entered into a collaboration agreement with Ajinomoto Co. Inc., Japan, for the joint development of novel fermentation production routes for a natural functional ingredient for application in Personal Care. During the 3½ year collaboration, Ajinomoto ... more

Evolva acquires resveratrol programme from Fluxome

Evolva has agreed to acquire all of Fluxome's scientific and technical assets related to resveratrol and hire a small number of its employees, integrating the programme into Evolva’s Danish operations. Evolva will not take over Fluxome’s US sales and marketing organisation but will instead ... more

More news by Evolva
Companies

Evolva SA

Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimise small molecule compounds and their production routes. We are active in consumer healthcare and nu ... more

More about IFF

News

Evolva reaches first milestone in IFF collaboration

Evolva Holding SA announced that International Flavors & Fragrances Inc. (IFF) has confirmed that Evolva has achieved the first milestone in their collaboration that was announced in January 2011. The ultimate objective of the collaboration is to implement a commercially viable biosynthetic ... more

Evolva expands collaboration with IFF

Evolva Holding SA announced that it has expanded its collaboration with International Flavors & Fragrances Inc. Evolva has been working with IFF since early 2011 to implement a commercially viable biosynthetic route for the sustainable production of a key flavouring ingredient. This projec ... more

Evolva enters into collaboration with International Flavors & Fragrances Inc.

Evolva Holding SA announced that it has entered into a collaboration and joint development agreement with International Flavors & Fragrances Inc. (IFF). The objective of the collaboration is to implement a commercially viable biosynthetic route for the production of a key flavoring ingred ... more